341 related articles for article (PubMed ID: 34724213)
1. The Effect of Povidone-Iodine Nasal Spray on Nasopharyngeal SARS-CoV-2 Viral Load: A Randomized Control Trial.
Zarabanda D; Vukkadala N; Phillips KM; Qian ZJ; Mfuh KO; Hatter MJ; Lee IT; Rao VK; Hwang PH; Domb G; Patel ZM; Pinsky BA; Nayak JV
Laryngoscope; 2022 Nov; 132(11):2089-2095. PubMed ID: 34724213
[TBL] [Abstract][Full Text] [Related]
2. Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: A structured summary of a study protocol for an open-label randomized clinical trial.
Hasan MJ; Rumi SKNF; Banu SS; Uddin AKMN; Islam MS; Arefin MK
Trials; 2021 Jan; 22(1):2. PubMed ID: 33397432
[TBL] [Abstract][Full Text] [Related]
3. Effect of the povidone iodine, hypertonic alkaline solution and saline nasal lavage on nasopharyngeal viral load in COVID-19.
Batioglu-Karaaltin A; Yigit O; Cakan D; Akgul O; Yigit E; Yilmaz YZ; Cakir KB; Ciftci G; Boyoğlu NS; Cagliyan A; Can E; Dikme O; Hacioglu Y; Balkan II; Enver O; Ozdogan HA
Clin Otolaryngol; 2023 Jul; 48(4):623-629. PubMed ID: 36973223
[TBL] [Abstract][Full Text] [Related]
4. A Pilot Study of 0.4% Povidone-Iodine Nasal Spray to Eradicate SARS-CoV-2 in the Nasopharynx.
Sirijatuphat R; Leelarasamee A; Puangpet T; Thitithanyanont A
Infect Drug Resist; 2022; 15():7529-7536. PubMed ID: 36575672
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of povidone-iodine nasal rinse and mouth wash in COVID-19 management: a prospective, randomized pilot clinical trial (povidone-iodine in COVID-19 management).
Alsaleh S; Alhussien A; Alyamani A; Alhussain F; Alhijji A; Binkhamis K; Khan A; Javer A; Alshahrani FS
BMC Infect Dis; 2024 Mar; 24(1):271. PubMed ID: 38429662
[TBL] [Abstract][Full Text] [Related]
6. Effect of 0.5% povidone-iodine on the nasopharyngeal and oropharyngeal viral loads in patients with COVID-19: A double-blind placebo-controlled randomized clinical trial.
Sharma P; Singh A; Singh NP; Takhelchangbam N; Kumar R; Yadav R
J Family Med Prim Care; 2022 Oct; 11(10):6320-6326. PubMed ID: 36618132
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
8. Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era.
Frank S; Capriotti J; Brown SM; Tessema B
Ear Nose Throat J; 2020 Nov; 99(9):586-593. PubMed ID: 32520599
[TBL] [Abstract][Full Text] [Related]
9. Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: an open-label randomized clinical trial.
Arefin MK; Rumi SKNF; Uddin AKMN; Banu SS; Khan M; Kaiser A; Chowdhury JA; Khan MAS; Hasan MJ
Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):2963-2967. PubMed ID: 34026595
[TBL] [Abstract][Full Text] [Related]
10. Effect of oral antiseptics on the viral load of SARS-CoV-2: A randomized controlled trial.
Sevinç Gül SN; Dilsiz A; Sağlık İ; Aydın NN
Dent Med Probl; 2022; 59(3):357-363. PubMed ID: 35904769
[TBL] [Abstract][Full Text] [Related]
11. Virucidal Effect of Povidone Iodine on SARS-CoV-2 in Nasopharynx: An Open-label Randomized Clinical Trial.
Kamal Arefin M; Banu SS; Nasir Uddin AKM; Nurul Fattah Rumi SK; Khan M; Kaiser A; Arafat MS; Chowdhury JA; Khan MAS; Hasan MJ
Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3283-3292. PubMed ID: 35572740
[TBL] [Abstract][Full Text] [Related]
12. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the effect of gargling with hydrogen peroxide and povidone-iodine on salivary viral load of SARS-CoV-2: A pilot randomized clinical trial.
Adl A; Sedigh-Shams M; Jamalidoust M; Rajabzadeh Z
Niger J Clin Pract; 2023 Apr; 26(4):391-396. PubMed ID: 37203101
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Mouth Rinses and Nasal Spray in the Inactivation of SARS-CoV-2: A Systematic Review and Meta-Analysis of
Idrees M; McGowan B; Fawzy A; Abuderman AA; Balasubramaniam R; Kujan O
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231450
[TBL] [Abstract][Full Text] [Related]
15. Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial.
Castellarnau A; Heery GP; Seta A; Luscombe CA; Kinghorn GR; Button P; McCloud P; Paull JRA
Sci Rep; 2022 Jun; 12(1):10210. PubMed ID: 35715644
[TBL] [Abstract][Full Text] [Related]
16. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
[TBL] [Abstract][Full Text] [Related]
17. A Review of Topical Povidone-iodine to Decrease Viral Load of COViD-19.
Benson KM; Mancini AA; Brodeur MR
Sr Care Pharm; 2021 May; 36(5):238-241. PubMed ID: 33879284
[TBL] [Abstract][Full Text] [Related]
18. Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 Outpatients.
De Boeck I; Cauwenberghs E; Spacova I; Gehrmann T; Eilers T; Delanghe L; Wittouck S; Bron PA; Henkens T; Gamgami I; Simons A; Claes I; Mariën J; Ariën KK; Bakokimi D; Loens K; Jacobs K; Ieven M; Bruijning-Verhagen P; Delputte P; Coenen S; Verhoeven V; Lebeer S
Microbiol Spectr; 2022 Oct; 10(5):e0168222. PubMed ID: 36154666
[TBL] [Abstract][Full Text] [Related]
19. Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19: A Randomized Clinical Trial.
Guenezan J; Garcia M; Strasters D; Jousselin C; Lévêque N; Frasca D; Mimoz O
JAMA Otolaryngol Head Neck Surg; 2021 Apr; 147(4):400-401. PubMed ID: 33538761
[TBL] [Abstract][Full Text] [Related]
20. Phase II Trial of the Impact 0.5% Povidone-Iodine Nasal Spray (Nasodine®) on Shedding of SARS-CoV-2.
Friedland PL; Tucker S
Laryngoscope; 2024 Mar; ():. PubMed ID: 38554057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
